Méhnyakrák: vizsgálatok itt: Ausztria
3 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
- Where
- Graz, Innsbruck, Salzburg, Vienna
- Életkor
- 18 év and over
- People
- 1023 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07216703 · EU 2025-521514-26-00 - 3. fázisTaking peopleIntermediate Risk Cervical Cancer: Radical Surgery +/- Adjuvant Radiotherapy
- Where
- Feldkirch, Graz, Leoben, St. Poelten, Vienna
- Életkor
- 18 év to 85 év
- People
- 514 worldwide
- Run by
- The Central and Eastern European Gynecologic Oncology Group
See details and how to joinNCT04989647 · EU 2023-504973-19-01 - 2. fázisTaking peopleImage Guided IMRT, Radiochemotherapy and MRI-based IGABT in Locally Advanced Cervical Cancer
- Where
- Vienna
- Életkor
- 18 év to 99 év
- People
- 1000
- Run by
- Medical University of Vienna
See details and how to joinNCT03617133